Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Mitogen-activated protein (MAP) kinases are proline-directed serine/threonine kinases that are activated by dual phosphorylation on threonine and tyrosine residues in response to a wide array of extracellular stimuli. Three distinct groups of MAP kinases have been identified in mammalian cells [extracellular-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38]. These MAP kinases are mediators of signal transduction from the cell surface to the nucleus. One nuclear target of these MAP kinase signaling pathways is the transcription factor AP-1. MAP kinases regulate AP-1 transcriptional activity by multiple mechanisms. Here we review recent progress towards understanding AP-1 regulation by the ERK, JNK, and p38 MAP kinase signal transduction pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“c-Jun forms homodimers or can heterodimerize with other Jun family members or with other bZIP proteins including members of the Fos and ATF/cAMP response element-binding protein (CREB) families (18,19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“The c-Jun promoter contains important TPA response elements that preferentially bind heterodimers of c-Jun and ATF-2, both of which are activated upon phosphorylation by JNK (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes [69, 70].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [70]
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Self-citationMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Self-citationIntegrins and Signal Transduction Pathways: the Road Taken
Clark, E. A., & Brugge, J. S. (1995) · Science · doi:10.1126/science.7716514 · Cited by 2,937
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,596
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Self-citation
Cited by
Items 901–1,000 of 1,001
Jin, R., Wang, Y., He, B., Zhang, Y., Cai, T., Wan, H., Jin, B. R., & Li, J. (2021) · Pest Management Science · doi:10.1002/ps.6482 · Cited by 29
Chen (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000177 · Cited by 28
“An intracellular signaling pathway that was recently impli - cated in the regulation of apoptosis is the mitogen activated protein kinase (MAPK) cascade (9,10).”
A global genomic view of MIF knockdown-mediated cell cycle arrest
Liu, L., Ji, C., Chen, J., Li, Y., Fu, X., Xie, Y., Gu, S., & Mao, Y. (2008) · Cell Cycle · doi:10.4161/cc.7.11.6011 · Cited by 30
Balaraman, S., Singh, V. K., Tewary, P., & Madhubala, R. (2004) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2004.10.006 · Cited by 28
Seldeen, K. L., McDonald, C. B., Deegan, B. J., & Farooq, A. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.024 · Cited by 31
Airway epithelium and apoptosis
Jyonouchi, H. (1999) · APOPTOSIS · doi:10.1023/a:1009607607603 · Cited by 28
Toll-like receptors and integrins crosstalk
Alhamdan, F., Bayarsaikhan, G., & Yuki, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1403764 · Cited by 33
“Upon in vivo challenge with TLR ligand stimulations (LPS, poly(I:C), and CpG) pro-in fl ammatory cytokines (TNF, IL-6, IL-10, and IFN-b ) were greatly increased in the serum of CD11b ( a M) KO mice (39).”
BackgroundTherapeutic targeting of ATR in alveolar rhabdomyosarcoma
García, H. D., Pusch, F. F., Bei, Y., von Stebut, J., Ibáñez, G., Guillan, K. C., Imami, K., Gürgen, D., Rolff, J., Helmsauer, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32023-7 · Cited by 34
Lu, Y., Suh, S., Li, X., Hwang, S., Li, Y., Hwangbo, K., Park, S. J., Murakami, M., Lee, S. H., Jahng, Y., et al. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.11.046 · Cited by 27
Moody, T. W., Leyton, J., Casibang, M., Pisegna, J. R., & Jensen, R. T. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00196-9 · Cited by 27
“Phosphorylated MAPK may enter the nucleus and alter nuclear oncogene expression [12].”
BackgroundLiu, Q., Liu, J., Röschmann, K., van Egmond, D., Golebski, K., Fokkens, W. J., Wang, D., & van Drunen, C. M. (2013) · Journal of Inflammation · doi:10.1186/1476-9255-10-15 · Cited by 29
Xiong, H., Zhou, S., Sun, A., He, Y., Li, J., & YUAN, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4052 · Cited by 27
“MAPKs participate in gene expression, cell proliferation, differentiation, cell mitosis and apoptosis (28).”
Gene Regulation of CYP4F11 in Human Keratinocyte HaCaT Cells
Wang, Y., Bell, J. C., Keeney, D. S., & Strobel, H. W. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.029025 · Cited by 27
“Cytokines and many other factors activate the AP-1 complex through multiple signaling pathways such as the c-Jun N-terminal kinase (JNK), P38, and extracellular signal-regulated kinase pathways (Whitmarsh and Davis, 1996).”
BackgroundSpecific Amino Acid Dependency Regulates the Cellular Behavior of Melanoma
Fu, Y., & Meadows, G. G. (2007) · Journal of Nutrition · doi:10.1093/jn/137.6.1591s · Cited by 28
Qu, F., Xiang, Z., Zhang, Y., Li, J., Xiao, S., Zhang, Y., Mao, F., Ma, H., & Yu, Z. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.10.001 · Cited by 28
Replication of SNP associations with keratoconus in a Czech cohort
Lišková, P., Ďuďáková, Ľ., Křepelová, A., Kléma, J., & Hysi, P. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172365 · Cited by 27
Jeon, Y. J., & Kim, H. M. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00065-0 · Cited by 30
Pontrelli, P., Ranieri, E., Ursi, M., Ghosh-Choudhury, G., Gesualdo, L., Schena, F. P., & Grandaliano, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00644.x · Cited by 27
“The dimerization of jun and fos to form AP-1 can be induced by several agonists through jun-N-terminal kinase (JNK) activation [22, 23].”
BackgroundLi, J., Foitzik, K., Calautti, E., Baden, H., Doetschman, T. C., & Dotto, G. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4213 · Cited by 31
Selective protein kinase inhibitors block head-specific differentiation in hydra
Cardenas, M., Fabila, Y., Yum, S., Cerbón, J., Böhmer, F., Wetzker, R., Fujisawa, T., Bosch, T. C. G., & Salgado, L. M. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00115-7 · Cited by 27
Dietary energy restriction inhibits ERK but not JNK or p38 activity in the epidermis of SENCAR mice
Liu, Y., Duysen, E. G., Yaktine, A. L., Au, A. P., Wang, W., & Birt, D. F. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.607 · Cited by 27
Mitsuyama, K., Suzuki, A., Matsumoto, S., Tomiyasu, N., Takaki, K., Takedatsu, H., Masuda, J., Handa, K., Harada, K., Nishida, H., et al. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02825.x · Cited by 27
Wilmer, W. A., Dixon, C. L., Hebert, C. L., Lu, L., & Rovin, B. H. (2002) · Antioxidants and Redox Signaling · doi:10.1089/152308602762197416 · Cited by 29
“Full transcription of a TRE gene by AP-1 occurs when the amino terminus of Jun is phosphorylated (44).”
Delcroix, J., Averill, S., Fernandes, K., Tomlinson, D. R., Priestley, J. V., & Fernyhough, P. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-18-j0002.1999 · Cited by 28
“At promoter sites of other genes, ATF-2 binds to the CRE and can heterodimerize with c-jun to form functional AP-1 complexes (Su and Karin, 1996; Whitmarsh and Davis, 1996).”
BackgroundInfluentialPapachristou, D. J., Papachroni, K. K., Papavassiliou, G. A., Pirttiniemi, P. M., Gorgoulis, V. G., Piperi, C., & Basdra, E. K. (2009) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2009.08.010 · Cited by 28
Hwang, Y. P., Kim, H. G., Choi, J. H., Han, E. H., Kwon, K., Lee, Y. C., Choi, J. M., Chung, Y., Jeong, T. C., & Jeong, H. G. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.10.002 · Cited by 27
C-Peptide Ameliorates Kidney Injury Following Hemorrhagic Shock
Chima, R. S., Maltese, G., Lamontagne, T., Piraino, G., Denenberg, A. G., O’Connor, M. P., & Zingarelli, B. (2011) · Shock · doi:10.1097/shk.0b013e31820b2e98 · Cited by 26
“Moreover, both ERK and JNK may phosphorylate and activate elements in the c-Fos promoter, thereby resulting in enhanced expression of c-Fos (20).”
BackgroundPan, J., Li, H., Zhang, B., Xiong, R., Zhang, Y., Kang, W., Chen, W., Zhao, Z., & Chen, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119204 · Cited by 26
“Activated JNK3 phosphorylates a variety of target proteins, including nuclear factors and mitochondrial proteins, leading to apoptosis and mitochondrial dysfunction [9].”
BackgroundSato, N., Moore, F. A., Smith, M. A., Zou, L., Moore‐Olufemi, S. D., Schultz, S. G., & Kozar, R. A. (2005) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000153937.04932.59 · Cited by 26
MAP kinase‐dependent, NF‐κB‐independent regulation of inhibitor of apoptosis protein genes by TNF‐α
Furusu, A., Nakayama, K., Xu, Q., Konta, T., & Kitamura, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20881 · Cited by 28
“Furthermore, c-Jun is phosphorylated and activated by JNK, and c-Fos is phosphorylated by a member of MAP kinase, Fosregulating kinase (Whitmarsh and Davis, 1996).”
BackgroundSubedi, L., Baek, S.-H., & Kim, S. Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8092713 · Cited by 27
“Interventions that can control JNK and ERK activation will alter the expression of AP-1 signaling [50, 51].”
BackgroundAnti-cancer potential of persimmon (Diospyros kaki) leaves via the PDGFR-Rac-JNK pathway
Kim, H.-S., Suh, J., Jang, Y., Ahn, S.-H., Ganesan, R., Kim, J., Jung, Y., Jung, S. H., & Kim, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-75140-3 · Cited by 27
Bose, C., Bhuvaneswaran, C., & Udupa, K. B. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.02.003 · Cited by 27
Bär, M., Domaschke, D., Meye, A., Lehmann, B., & Meurer, M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700493 · Cited by 26
Yoshimura, H., Nakahama, K., Safronova, O. S., Tanaka, N., Muneta, T., & Morita, I. (2006) · Inflammation Research · doi:10.1007/s00011-006-5144-9 · Cited by 26
“A major nuclear target of these MAPKs is the transcription factor AP-1 [34], and the expression of MCP-1 in human osteoblasts is regulated by MAPK pathways and activation of AP-1 [35].”
Induction of c-junand TGF-β1 in Fischer 344 rats during amiodarone-induced pulmonary fibrosis
Chung, W. H., Bennett, B. M., Racz, W. J., Brien, J. F., & Massey, T. E. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.5.l1180 · Cited by 29
C/EBPBeta and Elk-1 synergistically transactivate the c-fos serum response element
Hanlon, M., Bundy, L. M., & Sealy, L. J. (2000) · BMC Cell Biology · doi:10.1186/1471-2121-1-2 · Cited by 28
“In addition, the TCFs have been found to be targets for all three families of MAPKs: the extracellular signal-regulated kinases 1/2 (ERK1/2), the jun-N-terminal kinases/stress activated protein kinases (JNK/SAPK), and the p38 kinase [17, 18].”
BackgroundSanz, V., Arozarena, I., & Crespo, P. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01598-2 · Cited by 26
Migita, K., Miyashita, T., Ishibashi, H., MAEDA, Y., Nakamura, M., Yatsuhashi, H., Ida, H., Kawakami, A., Aoyagi, T., Kawabe, Y., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02555.x · Cited by 26
Nitric oxide induces apoptosis via AP-1-driven upregulation of COX-2 in rat pheochromocytoma cells
Li, M., Jang, J.-H., & Surh, Y. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.015 · Cited by 26
Desiderio, M. A., Pogliaghi, G., & Dansi, P. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4073 · Cited by 26
RetractedModulation of cellular AP‐1 DNA binding activity by heat shock proteins
Carter, D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01174-5 · Cited by 26
Kitamura, M., & Ishikawa, Y. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00706.x · Cited by 34
“Alternatively, the tyrosine kinase-mediated activation of the Ras–Raf mitogen-activated protein kinase pathway may induce c- fos expression and thereby augment the activity of AP-”
BackgroundChen, P., Zhao, D., Sun, Y., HUANG, L., Zhang, S., & Yuan, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.2030 · Cited by 26
A Journey Through Mitogen-Activated Protein Kinase and Ochratoxin A Interactions
Rumora, L., & Grubišić, T. Ž. (2009) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/10004-1254-60-2009-1969 · Cited by 25
Silica-Induced TNF-αand TGF-β1 Expression in RAW264.7 Cells are Dependent on Src-ERK/AP-1 Pathways
Li, X., Hu, Y., Jin, Z., Jiang, H., & Wen, J. (2008) · Toxicology Mechanisms and Methods · doi:10.1080/15376510802354201 · Cited by 25
“It was reported that AP-1 is regulated by MAPKs (Whitmarsh and Davis 1996).”
BackgroundAnti-inflammatory effects ofRubus coreanusMiquel through inhibition of NF-κB and MAP Kinase
Lee, J. E., Cho, S., Park, E., Lee, S. M., Kim, Y., Auh, J., Choi, H.-K., Lim, S., Lee, S. C., & Kim, J. (2014) · Nutrition Research and Practice · doi:10.4162/nrp.2014.8.5.501 · Cited by 28
“Phosphorylated MAP kinase activates AP-1 consisting of c-Jun and c-Fos, and then activates AP-1, a transcriptional factor that regulates inflammatory responses via modulation of expression of inflammatory mediator [31-33].”
BackgroundZhang, H. A., Wang, M., Zhou, J., Yao, Q., Ma, J. M., & Jiang, C. L. (2010) · Physiological Research · doi:10.33549/physiolres.931650 · Cited by 25
Yoshioka, Y., Kadoi, H., Yamamuro, A., Ishimaru, Y., & Maeda, S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.041 · Cited by 28
“Transcription of GCLc has been known to be regulated by transcriptional factors such as nuclear factor-erythroid 2-related factor-2 (Nrf2), activator protein 1 (AP-1), and nuclear factor-kappa B (NF-κB; Day et al., 2002; Kawakita et al., 2003; Kurozumi and Kojima, 2005).”
BackgroundBarnea, A., Roberts, J., Keller, P. W., & Word, R. A. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02141-2 · Cited by 35
An, L., Dong, G., Gao, Q., Zhang, Y., Hu, L., Li, J.-H., & Liu, Y. (2010) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2009.00481.x · Cited by 33
Wu, A.-H., & Low, W. C. (2003) · Neuro-Oncology · doi:10.1215/s1152851702000510 · Cited by 25
Rui, T., & Kvietys, P. R. (2005) · The FASEB Journal · doi:10.1096/fj.05-4028fje · Cited by 25
“This rapid increase in AP-1 is most likely due to the mobilization of preformed pools of AP-1 (24, 25 ), rather than induction of the components of AP-1, c-jun, and c-fos.”
IL-7 withdrawal induces a stress pathway activating p38 and Jun N-terminal kinases
Rajnavölgyi, É., Benbernou, N., Réthi, B., Reynolds, D. A., Young, H. A., Magócsi, M., Muegge, K., & Durum, S. K. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00026-8 · Cited by 25
Turchi, L., Loubat, A., Rochet, N., Rossi, B., & Ponzio, G. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5060 · Cited by 29
Tong, Z., Singh, G., Valerie, K. C., & Rainbow, A. J. (2003) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2003.08.001 · Cited by 25
Yazlovitskaya, E. M., Pelling, J. C., & Persons, D. L. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199905)25:1<48::aid-mc6>3.0.co;2-6 · Cited by 25
Bombesin activates MAP kinase in non-small cell lung cancer cells
Koh, S. M., Leyton, J., & Moody, T. W. (1999) · Peptides · doi:10.1016/s0196-9781(98)00144-2 · Cited by 25
The lectin jacalin induces phosphorylation of ERK and JNK in CD4+ T cells
Tamma, S. M. L., Kalyanaraman, V. S., Pahwa, S. G., Dominguez, P., & Modesto, R. R. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102534 · Cited by 25
ERK MAP KINASE IS REQUIRED IN 1,25(OH)2D3-INDUCED DIFFERENTIATION IN HUMAN OSTEOBLASTS
Chae, H., Jeong, B. J., Ha, M. S., Lee, J. K., Byun, J.-S., Jung, W. Y., Yun, Y. G., Lee, D. G., Oh, S. H., Chae, S., et al. (2002) · Immunopharmacology and Immunotoxicology · doi:10.1081/iph-120003401 · Cited by 26
Apoptosis in polycystic ovary syndrome: Mechanisms and therapeutic implications
Yang, L.-K., Ma, W., Wang, X., Chen, H.-R., Jiang, Y., & Sun, H. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123394 · Cited by 26
Wagner, M., Hintner, H., Bauer, J. W., & Önder, K. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01420.x · Cited by 26
Priyamvada, S., Anbazhagan, A. N., Kumar, A., Soni, V., Alrefai, W. A., Gill, R. K., Dudeja, P. K., & Saksena, S. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00210.2015 · Cited by 24
Bwalya, E. C., Kim, S., Fang, J., Wijekoon, S., Hosoya, K., & Okumura, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177144 · Cited by 35
Potentiated anticancer effects on hepatoma cells by the retinoid adapalene
Ocker, M., HEROLD, C., GANSLMAYER, M., Zopf, S., HAHN, E., & SCHUPPAN, D. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.12.026 · Cited by 24
Yang, W. S., Chang, J. W., Han, N. J., Lee, S. K., & Park, S.-K. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.05.016 · Cited by 24
Methotrexate induces interleukin-8 production by human bronchial and alveolar epithelial cells
Yamauchi, Y., Okazaki, H., Desaki, M., Kohyama, T., Kawasaki, S., Yamamoto, K., & Takizawa, H. (2004) · Clinical Science · doi:10.1042/cs20030262 · Cited by 24
Hayashi, S., Koshiba, K., Hatashita, M., Sato, T., Jujo, Y., Suzuki, R., Tanaka, Y., & Shioura, H. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.760 · Cited by 25
“…extracellular-regulated kinase (ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 (17-20), which are mediators of signal transduction from the cell surface to the nucleus (21). c-Jun/AP-1 activation has been implicated in various, often opposing, cellular responses.”
Park, K., Kim, J., Kim, E.-C., Yun, H., & Hong, J. T. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0932-z · Cited by 24
“Our data also showed that 4-O-MH markedly downregulated the expression of c-Fos and NFATc1 (osteoclast differentiation genes) as well as TRAP and ITB3 (osteoclast-expressed genes).”
BackgroundInfluentialNgwa, H. A., Ay, M., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-60189-2_14 · Cited by 24
Tenda, Y., Yamashita, M., Kimura, M. Y., Hasegawa, A., Shimizu, C., Kitajima, M., Onodera, A., Suzuki, A., Seki, N., & Nakayama, T. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.05.024 · Cited by 27
Cytoprotective Effects of KIOM-79 on Streptozotocin Induced Cell Damage by Inhibiting ERK and AP-1
Kang, K. A., Lee, K. H., Kim, S. Y., Kim, H. S., Kim, J. S., & Hyun, J. W. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.852 · Cited by 24
Chen, Q., Edvinsson, L. I., & Xu, C. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.201 · Cited by 25
“AP-1 is a transcription factor that can be activated upstream by three groups of MAPK signal pathways (ERK1/2, p38, and JNK) and involved in a variety of cellular responses[33].”
BackgroundSharabi, A., Lapter, S., & Mozes, E. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.06.002 · Cited by 24
“Therefore, the ability of hCDR1 to reduce the levels of pJNK [15] may impair the formation of AP-1 [39], and as a result, NFAT will become more available for association with Foxp3 instead of with AP-1, thereby promoting the differentiation of anergized/regulatory cells [40,41].”
BackgroundMizuochi, Y., Okajima, K., Harada, N., Molor-Erdene, P., Uchiba, M., Komura, H., Tsuda, T., & Katsuya, H. (2007) · Translational research · doi:10.1016/j.trsl.2006.11.008 · Cited by 25
The oncogenic TEL/PDGFRβ fusion protein induces cell death through JNK/SAPK pathway
Atfi, A., Prunier, C., Mazars, A., Defachelles, A. S., Cayre, Y. E., Gespach, C. P., & Bourgeade, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202734 · Cited by 24
“Once activated, ERKs translocate to the nucleus where they phosphorylate and activate the transcription factor ELK-1 (Whitmarsh and Davis, 1996; Gille et al., 1992).”
BackgroundNaso, M. F., Uitto, J., & Klement, J. F. (2003) · Journal of Investigative Dermatology · doi:10.1111/j.1523-1747.2003.12640.x · Cited by 25
“AP1 is a versatile transcription factor, as it is a target of many signal transduction pathways involved in cell proliferation, di¡erentiation, and cell death (Whitmarsh and Davis, 1996; Karin et al, 1997; Hocevar and Howe, 2000).”
BackgroundNaraba, H., Ueno, A., Kosugi, Y., Yoshimura, M., Murakami, M., Kudo, I., & Oh‐ishi, S. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01045-x · Cited by 25
Przybyszewski, J., Yaktine, A. L., Duysen, E., Blackwood, D., Wang, W., Au, A., & Birt, D. F. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1421 · Cited by 29
“Consequences of DER on AP-1 were characterized by measuring DNA-binding ability, c-Jun protein and c-jun message because the AP-1 transcription factor is composed of a Jun protein complexed with another Jun protein or with a Fos protein to form the Jun/Jun or Jun/Fos transcription factor, which acts as a positive or n…”
BackgroundZhang, G., He, L., Wong, Y. H., & Qian, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069510 · Cited by 25
“Mitogen-activated protein kinase (MAPK) pathways are wellstudied in mammalian cells and known to regulate many biological processes, such as cell proliferation, differentiation and death [8], [9].”
BackgroundHyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer
Vafeiadou, V., Hany, D., & Picard, D. (2022) · Cancers · doi:10.3390/cancers14040954 · Cited by 27
“In addition, we performed a luciferase reporter assay to assess the activity of the transcription factor AP-1, a well-known ERK1/2 target [57]; this experiment revealed that AP-1, without any specific stimulation, is significantly more active after SPRED2 depletion (Figure S3H).”
MethodModulation of protein kinase signaling cascades by palytoxin
Wattenberg, E. V. (2010) · Toxicon · doi:10.1016/j.toxicon.2010.11.003 · Cited by 23
“…ERK1/2, JNK, and p38 also all modulate the AP-1 family of transcription factors, which are dimers made up of various combinations of Jun and Fos family members (Angel and Karin, 1991; Gille et al., 1995; Whitmarsh et al., 1995; Raingeaud et al., 1996; Whitmarsh and Davis, 1996; Karin et al., 1997).”
BackgroundTiwari, A. K., & Roy, J. K. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2009.02.188 · Cited by 23
New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells
Taylor, J. L., Szmulewitz, R. Z., Lotan, T. L., Hickson, J. A., Griend, D. J. V., Yamada, S. D., Macleod, K. F., & Rinker-Schaeffer, C. W. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.012 · Cited by 25
Ginsenoside Rg3 Suppresses Palmitate-Induced Apoptosis in MIN6N8 Pancreatic β-Cells
Kim, K., Park, M. S., & Kim, H. Y. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.09-49 · Cited by 27
Impact of Aging on Steroid Hormone Biosynthesis and Secretion
Zaidi, S. K. (2012) · Open Longevity Science · doi:10.2174/1876326x01206010001 · Cited by 26
“AP-1 activity is regulated at various levels, including transcriptional and post-transcriptional mechanisms leading to increased AP-1 expression and post-translational modifications, such as phosphorylation, post-translational processing and turnover or pre-existing or newly synthesized AP-1 subunits and oxidation/red…”
BackgroundLiu, Y., Wk, Z., Ws, G., Shen, Y., & Ding, W.-Y. (2013) · PubMed · Cited by 27
Leewananthawet, A., Arakawa, S., Okano, T., Kinoshita, R. D., Ashida, H., Izumi, Y., & Suzuki, T. (2019) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2019.1614980 · Cited by 23
“In general, the cellular protection against oxidative stress was induced by variety of stimuli such as H2O2, MAPK pathways, including p38 MAPK, SAPK/JNK and Erk1/2 [14,15]. p38 MAPK is also involved in the induction of hyperresponsiveness and inflammation in the airways after inhalation of gaseous ozone [19].”
BackgroundMethodInfluentialMarciniak, J., Lossdörfer, S., Knaup, I., Bastian, A., Craveiro, R. B., Jäger, A., & Wolf, M. F. (2019) · Clinical Oral Investigations · doi:10.1007/s00784-019-03111-8 · Cited by 23
Abdel-Latif, M., Windle, H. J., Terres, A. M., Eidhin, D. N., Kelleher, D. P., & Reynolds, J. V. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.09.003 · Cited by 28
“This addressed whether MAPK pathways are involved in NF-kB and AP-1 by HPE, as MAPK pathways have been shown to be involved in AP-1 induction.(21) To determine the signalling pathways involved in NF-kB induction by HPE, a panel of MAP kinase inhibitors were used.”
p38MAPK inhibitor SB203580 sensitizes human SNU-C4 colon cancer cells to exisulind-induced apoptosis
Lim, S., Lee, Y.-J., & Lee, E. (2006) · Oncology Reports · doi:10.3892/or.16.5.1131 · Cited by 23
“The role of mitogen-activated protein kinase (MAPK) cascade has been implicated in signal transduction and the regulation of cell survival and death response to diverse external stimuli (3,4).”
Role of Gab1 in UV-Induced c-Jun NH2-Terminal Kinase Activation and Cell Apoptosis
Sun, Y., Yuan, J., Liu, H., Shi, Z., Baker, K. K., Vuori, K., Wu, J., & Feng, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1531-1539.2004 · Cited by 23
“Characterization of fibroblast cells defective for c-Jun or c-Fos expression even suggested a protective role of JNK against cell apoptosis (30, 41).”
BackgroundSakiyama, S., de Perrot, M. E., Han, B., Waddell, T. K., Keshavjee, S. H., & Liu, M. (2003) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00553-3 · Cited by 23
Kielosto, M., Nummela, P., Katainen, R., Leaner, V. D., Birrer, M. J., & Hölttä, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3188-2 · Cited by 23
“c-Jun is phosphorylated by specific kinases called c-Jun NH2-terminal kinases (JNKs) and in some cell types also by mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK)-mediated mechanisms (7, 8).”
BackgroundPena, E., Berciano, M. T., Fernández, R., Crespo, P., & Lafarga, M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4814 · Cited by 23
Crowe, D. L., Brown, T. N., Kim, R. H., Smith, S. M., & Lee, M. K. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0221 · Cited by 23
Nebivolol Inhibits Human Aortic Smooth Muscle Cell Growth: Effects on Cell Cycle Regulatory Proteins
André, D. E., Arnet, U. A., Yang, Z., & Lüscher, T. F. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200006000-00003 · Cited by 23
Molecular Regulation of Inducible Nitric Oxide Synthase
Ganster, R. W., & Geller, D. A. (2000) · Elsevier eBooks · doi:10.1016/b978-012370420-7/50009-5 · Cited by 27
Anti‐tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancer
Javadinia, S. A., Gholami, A., Mashhad, M. J., Ferns, G. A., Shahidsales, S., Avan, A., & Kermani, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26613 · Cited by 22
“Another mechanism of tumoral cell growth in gastro-esophageal cancers is activation of the mitogen-activated protein kinase (MARK) path (Souza, Shewmake, Terada, & Spechler, 2002; Whitmarsh & Davis, 1996).”
BackgroundLee, J.-H., Choi, J., & Kim, S. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13137 · Cited by 23
“NF-κB and AP-1 are two pivotal transcription factors that modulate LPS-mediated inflammatory responses by triggering the expression of a variety of pro-inflammatory mediators (Whitmarsh and Davis, 1996; Hayden and Ghosh, 2004).”
Background
Metadata
- Authors
- Whitmarsh, A. J., & Davis, R. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Molecular Medicine
- Published
- 1996-10
- Volume
- 74
- Issue
- 10
- Pages
- 589-607
- ISSN
- 0946-2716 (ISSN-L)
- OpenAlex
- W2031272027
- Cited by
- 1,543
- References
- 207
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 22 · 2023: 25 · 2022: 22 · 2021: 19 · 2020: 27 · 2019: 20 · 2018: 28 · 2017: 29 · 2016: 29 · 2015: 39 · 2014: 34 · 2013: 40 · 2012: 37
- FWCI
- 24.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- AP-1 transcription factor, mitogen-activated protein kinase, ERK, c-Jun N-terminal kinase, p38 MAPK, MAPK signaling, transcriptional regulation, dual phosphorylation, signal transduction
- MeSH terms
- Animals, Humans, Mammals, Signal Transduction, Calcium-Calmodulin-Dependent Protein Kinases, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.